本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Xeris製藥

7.45
-0.2200-2.87%
盤後7.450.00000.00%19:30 EDT
成交量:240.35萬
成交額:1,801.68萬
市值:13.58億
市盈率:-73.04
高:7.89
開:7.89
低:7.40
收:7.67
52周最高:10.08
52周最低:5.25
股本:1.82億
流通股本:1.73億
量比:1.37
換手率:1.39%
股息:- -
股息率:- -
每股收益(TTM):-0.1020
每股收益(LYR):0.0032
淨資產收益率:-617.16%
總資產收益率:6.13%
市淨率:-139.54
市盈率(LYR):2,323.04

資料載入中...

2026/03/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/02

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/27

重要事件披露

Form 8-K - Current report
2026/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/08

重要事件披露

Form 8-K - Current report
2025/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

重要事件披露

Form 8-K - Current report
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]